跳至主要内容
临床试验/JPRN-UMIN000032201
JPRN-UMIN000032201已完成未知

Randomized control study to evaluate efficacy and safety of tenofovir alafenamide fumarate for chronically HBV-infected patients treated with entecavir - Randomized control study to evaluate efficacy and safety of TAF for chronically HBV-infected patients treated with ETV

Department of Gastroenterology, Tohoku University Hospital0 个研究点目标入组 120 人开始时间: 2018年4月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who are treated with interferon (2) Patients who are treated with immunosuppressants (3) Patients who have or had hepatocellular carcinoma, or other malignancies (4) Patients who have decompensated liver cirrhosis (5) Patients whose phosphorus is lower than 2.5 mg/dl (6) Patients who are pregnant or have possibilities of pregnancy (7) Patients who are breastfeeding (8) Patients who are infected HIV or HCV (9) Patients who are participating other researches (10) Patients who are considered to be inappropriate for this study

研究者

发起方
Department of Gastroenterology, Tohoku University Hospital

相似试验